DeferiproneMultisystem disorders: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1566卷 / 1期

关键词：

D O I：

10.1007/s40278-015-4701-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：84 / 84

相关论文

共 50 条

[41] Adderall/methylphenidatePsychodermatological disorders: 4 case reports
Reactions Weekly, 2007, 1177 (1) : 5 - 5
[42] Interferons/ribavirinSkin disorders: 4 case reports
Reactions Weekly, 2012, 1394 (1) : 27 - 27
[43] Multiple drugsCardiovascular disorders and endocrine disorders: 4 case reports
Reactions Weekly, 2020, 1811 (1) : 191 - 191
[44] Nivolumab/pembrolizumabGastrointestinal disorders, lung disorders and skin disorders: 4 case reports
Reactions Weekly, 2022, 1934 (1) : 352 - 352
[45] OxybutyninCognition disorders in elderly patients: 4 case reports
Reactions Weekly, 1997, 679 (1) : 10 - 10
[46] Indinavir/ritonavir/saquinavirCoronary disorders: 4 case reports
Reactions Weekly, 2002, 896 (1) : 10 - 10
[47] AntineoplasticsThyroid disorders and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1942 (1) : 43 - 43
[48] Enzalutamide/relugolixHeart-disorders: 4 case reports
Reactions Weekly, 2023, 1981 (1) : 170 - 170
[49] Adalimumab/etanercept/infliximabLung disorders: 4 case reports
Reactions Weekly, 2008, 1210 (1) : 6 - 6
[50] Ipilimumab/nivolumab/pembrolizumabThyroid disorders: 4 case reports
Reactions Weekly, 2022, 1902 (1) : 256 - 256

← 1 2 3 4 5 →